InVivoMAb anti-WNV E protein DI-DII
BE0430
ApplicationsFlow Cytometry, ELISA, Neutralisation/Blocking, Other Application
Product group Antibodies
ReactivityVirus
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-WNV E protein DI-DII
- Delivery Days Customer7
- ApplicationsFlow Cytometry, ELISA, Neutralisation/Blocking, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDE53
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostMouse
- IsotypeIgG2a
- ReactivityVirus
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Goo L, Debbink K, Kose N, et al. A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions. Nat Microbiol. 2019,4(1):71-77. doi: 10.1038/s41564-018-0283-7Read this paper
- Goo L, VanBlargan LA, Dowd KA, et al. A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis. PLoS Pathog. 2017,13(2):e1006178. doi: 10.1371/journal.ppat.1006178Read this paper
- Poore EA, Slifka DK, Raué HP, et al. Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine. Vaccine. 2017,35(2):283-292. doi: 10.1016/j.vaccine.2016.11.080Read this paper
- Zhao H, Fernandez E, Dowd KA, et al. Structural Basis of Zika Virus-Specific Antibody Protection. Cell. 2016,166(4):1016-1027. doi: 10.1016/j.cell.2016.07.020Read this paper
- Vogt MR, Dowd KA, Engle M, et al. Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms. J Virol. 2011,85(22):11567-80. doi: 10.1128/JVI.05859-11Read this paper
- Mukherjee S, Lin TY, Dowd KA, et al. The infectivity of prM-containing partially mature West Nile virus does not require the activity of cellular furin-like proteases. J Virol. 2011,85(22):12067-72. doi: 10.1128/JVI.05559-11Read this paper
- Rodenhuis-Zybert IA, Moesker B, da Silva Voorham JM, et al. A fusion-loop antibody enhances the infectious properties of immature flavivirus particles. J Virol. 2011,85(22):11800-8. doi: 10.1128/JVI.05237-11Read this paper
- Dowd KA, Jost CA, Durbin AP, et al. A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus. PLoS Pathog. 2011,7(6):e1002111. doi: 10.1371/journal.ppat.1002111Read this paper
- Nelson S, Jost CA, Xu Q, et al. Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. PLoS Pathog. 2008,4(5):e1000060. doi: 10.1371/journal.ppat.1000060Read this paper
- Oliphant T, Nybakken GE, Engle M, et al. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J Virol. 2006,80(24):12149-59.Read this paper
